CHEOY:OTCMKTS
Cochlear Ord ADR
US$Â 44.72
arrow_downward
-0.07%(-0.030) Siku 1
15 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CHEOY...
Fungua
US$Â 44.61
Juu
US$Â 44.82
Chini
US$Â 44.60
Mtaji wa soko
8.58B
Wastani wa kiasi cha mauzo
elfu 18.50
Kiasi cha mauzo ya hisa
elfu 26.66
Juu kwa wiki 52
US$Â 98.49
Chini kwa wiki 52
US$Â 31.82
Beta
0.68
Hisa za wawekezaji
130.80M
Idadi ya wafanyakazi
elfu 5
Fungua
US$Â 44.61
Juu
US$Â 44.82
Chini
US$Â 44.60
Mtaji wa soko
8.58B
Wastani wa kiasi cha mauzo
elfu 18.50
Kiasi cha mauzo ya hisa
elfu 26.66
Juu kwa wiki 52
US$Â 98.49
Chini kwa wiki 52
US$Â 31.82
Beta
0.68
Hisa za wawekezaji
130.80M
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
saa 14 zilizopita
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
siku 1 iliyopita
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Wasifu
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Kuhusu Cochlear Ord ADR
Afisa Mkuu Mtendaji (CEO)Dig Howitt
Wafanyakazielfu 5.4
Lilianzishwa1981
Makao makuuSydney, New South Wales, Australia
Sekta-
Tovuticochlear.com